Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease

被引:0
|
作者
Yi, Jiahong [1 ]
Guo, Hui [2 ]
Jiang, Chang [1 ]
Duan, Junyi [3 ]
Xue, Ju [1 ]
Zhao, Yue [1 ]
He, Wenzhuo [1 ]
Xia, Liangping [1 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Prov Clin Res Ctr Canc, Canc Ctr,Dept VIP Reg,State Key Lab Oncol South Ch, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Prov Clin Res Ctr Canc, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Peoples R China
[3] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Dept Obstet & Gynecol, Zhuhai, Peoples R China
来源
关键词
alcohol-associated liver disease; all-cause mortality; leukocyte telomere length; NHANES; prognosis; SENESCENCE; HEPATITIS; PATHOGENESIS; FIBROSIS;
D O I
10.3389/fendo.2024.1462591
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is necessary to find latent indicators to predict the survival of alcohol-associated liver disease (ALD) patients. Leukocyte telomere length (LTL) was regarded as an indicator of prognosis in several diseases. However, the relationships between LTL and survival as well as cause-specific mortality in ALD patients were still unknown. Objective: This study aimed at exploring the underlying link between LTL and the risk of mortality in patients with ALD. Methods: The LTL and survival data were gathered from the National Health and Nutrition Examination Survey (NHANES) 1999-2002. The connection between LTL and mortality was assessed by Cox regression models and stratified analyses. The non-linear relationship was explored by restricted cubic spline (RCS) analysis. Sensitivity analyses were used to evaluate the robustness of our findings. Results: LTL was a negative factor for all-cause mortality (all p-value < 0.05). The risk of cardiovascular disease (CVD)-related death was decreased in Q3 (p < 0.001) and Q4 levels of LTL (p < 0.001) compared with the Q1 group. Shorter LTL resulted in higher cancer-caused mortality (p = 0.03) in the Q2 group. Longer LTL improved survival especially for elder patients (p for trend < 0.001) or men (p for trend = 0.001). Moreover, there were L-shaped correlations between LTL and all-cause mortality (p for non-linearity = 0.02), as well as cancer-related mortality (p for non-linearity < 0.001). Four sensitivity analyses proved the robustness of our findings. Conclusion: Our research found that longer LTL improved survival in patients with ALD and decreased CVD and cancer-related mortality. LTL decreased all-cause mortality especially for patients older than 65 years or men. LTL might be a useful biomarker for prognosis among patients with ALD. More prospective studies are needed to assess the relevance between LTL and mortality and explore the underlying mechanisms between them.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Liver Iron Loading in Alcohol-Associated Liver Disease
    Ali, Najma
    Ferrao, Kevin
    Mehta, Kosha J.
    AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (10): : 1427 - 1439
  • [42] HEAVY ALCOHOL CONSUMPTION IS ASSOCIATED WITH SHORTENED DNA METHYLATION TELOMERE LENGTH - IMPLICATION FOR ALCOHOL-ASSOCIATED AGING
    Jung, J.
    Wagner, J.
    Loho, F. W.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 121A - 121A
  • [43] The landscape of liver transplantation for patients with alcohol-associated liver disease in the United States
    Vock, David M.
    Humphreville, Vanessa
    Ramanathan, Karthik V.
    Adams, Andrew B.
    Lim, Nicholas
    Nguyen, Vinh H.
    Wothe, Jillian K.
    Chinnakotla, Srinath
    LIVER TRANSPLANTATION, 2025, 31 (01) : 32 - 44
  • [44] Complications in Patients with Alcohol-Associated Liver Disease Who Undergo Liver Transplantation
    Gaglio, Paul J., Jr.
    Gaglio, Paul J., Sr.
    CLINICS IN LIVER DISEASE, 2012, 16 (04) : 865 - +
  • [45] Association of Telomere Length With Risk of Disease and Mortality
    Schneider, Carolin, V
    Schneider, Kai Markus
    Teumer, Alexander
    Rudolph, Karl Lenhard
    Hartmann, Daniel
    Rader, Daniel J.
    Strnad, Pavel
    JAMA INTERNAL MEDICINE, 2022, 182 (03) : 291 - 300
  • [46] The lymphatic system in alcohol-associated liver disease
    Kondo, Reiichiro
    Iwakiri, Yasuko
    CLINICAL AND MOLECULAR HEPATOLOGY, 2020, 26 (04) : 633 - 638
  • [47] Advances in the management of alcohol-associated liver disease
    Anouti, Ahmad
    Kerr, Thomas A.
    Mitchell, Mack C.
    Cotter, Thomas G.
    GASTROENTEROLOGY REPORT, 2024, 12
  • [48] Dietary cholesterol in alcohol-associated liver disease
    Jia, Lin
    IMMUNOMETABOLISM, 2023, 5 (02) : E00026
  • [49] Rifaximin-α in alcohol-associated liver disease
    Xie, Chencheng
    Singal, Ashwani K.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (06): : 495 - 497
  • [50] Gut Microbiome and Alcohol-associated Liver Disease
    Philips, Cyriac A.
    Schnabl, Bernd
    Bajaj, Jasmohan S.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (05) : 1349 - 1359